Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon for Delirium and Sleep in ICU Patients
NCT03931070Phase 4Completed
- Sponsor
- Rhode Island Hospital
- Start
- May 2019
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in delirium comparing Ramelteon with Placebo (2 arms). Primary endpoint: Delirium- and coma-free days at 30 days. Started May 2019; status: completed.
02
Drugs
ramelteon
03
Conditions
delirium
Beyond the preview
Go deeper on NCT03931070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03931070.